Targeting the Sonic Hedgehog (SHH) pathway at the level of Smoothened suppresses glioma malignancy by upregulating miR200 and consequently blocking ZEB1 (Fu et al., 2013). The gene discussed is ZEB1; the disease is central nervous system cancer.